Strategy, Scale, and Survival in a Maturing Adult-Use Market
We are not out of the woods yet
In an industry defined by local operators struggling to stay afloat and confined within their borders, Michael Sassano, founder and CEO of Somai Pharmaceuticals, has created a blueprint for scaling cannabis worldwide with pharmaceutical discipline and regulatory agility. With headquarters in Lisbon and operations in 12 countries today, Somai is preparing to reach 18…
Discussions on the overlooked potential of these powerful compounds are on the rise
Inside the minds of New Jersey’s top cultivators
Panelists share lessons on partnerships, outsourcing, AI adoption, and capital strategy as the cannabis market shifts from expansion to efficiency.
Director Kellum outlines his goals, the challenges he faces steering this complex industry, and the dynamics that create roadblocks and impede progress.
As pricing pressure builds, operators in both states are navigating a tightly linked regional market shaped by shared consumers, cross-border expansion, and evolving brand dynamics.
Tissue culture is emerging as a critical tool in modern cultivation, enabling breeders and cultivators to advance disease-free genetics, consistency, cost efficiency, and scalable production.
The Super Bowl has long been one of the most important sales moments of the year for alcohol, food, and consumer packaged goods. Cannabis, however, has been left out of the conversation, often due to regulatory complexity, limited retail data, and conservative planning assumptions. However, new purchase data suggests a missed opportunity. Cannabis Is Already…
